Debra Kimless, MD

Debra Kimless, MD

CMO

Deb Kimless oversees our clinical medical testing,  patient and physician educational programs, and medical product development.   As a board-certified anesthesiologist and pain medicine specialist, she focuses on the pain-relieving aspects of cannabinoids and related substances for our FDA drug development program. Her recent election to the Bd. of Directors / Int’l Association for Cannabinoid Medicine has given her a world-wide educational platform for cannabis medicine. Deb graduated magna cum laude, Phi Beta Kappa from Muhlenberg College, earned her M.D. at Rutgers University and completed her anesthesiology residency at Temple University.